{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"immature-ovarian-teratoma","columns":[],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":[],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"not available","narrativeSourceChanges":[],"records":0,"sourceGroups":{}},"features":[],"ledeHtml":"A malignant germ cell tumor arising from the ovary. It usually affects females in their first two decades of life. It contains variable amounts of immature embryonal tissues. Based on the amount of immature neuroepithelial component, immature teratomas are graded from 1 to 3. The stage and grade of the tumor and the grade of the metastatic tumor are the important factors that predict prognosis. The use of cisplatin-based combination chemotherapy has significantly improved the survival rates of the patients.","mondoId":"MONDO:0018369","node":{"canonicalSlug":"immature-ovarian-teratoma","comparisons":[],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"immature ovarian teratoma","paragraphs":["A malignant germ cell tumor arising from the ovary. It usually affects females in their first two decades of life. It contains variable amounts of immature embryonal tissues. Based on the amount of immature neuroepithelial component, immature teratomas are graded from 1 to 3. The stage and grade of the tumor and the grade of the metastatic tumor are the important factors that predict prognosis. The use of cisplatin-based combination chemotherapy has significantly improved the survival rates of the patients."],"scope":"exact","source":"MONDO","upstream":"NCIT:C8111","url":"https://monarchinitiative.org/MONDO:0018369"},"ownColumnKeys":[],"publication":"published","relationships":[{"kind":"parent","label":"malignant teratoma","mondoId":"MONDO:0003514","slug":null},{"kind":"parent","label":"ovarian biphasic or triphasic teratoma","mondoId":"MONDO:0003821","slug":"ovarian-biphasic-or-triphasic-teratoma"},{"kind":"parent","label":"malignant non-dysgerminomatous germ cell tumor of ovary","mondoId":"MONDO:0016096","slug":null},{"kind":"child","label":"malignant struma ovarii","mondoId":"MONDO:0003332","slug":"malignant-struma-ovarii"},{"kind":"child","label":"childhood immature teratoma of ovary","mondoId":"MONDO:0004082","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Public source record is not available in the frozen inputs","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/21654"}],"translation":"published"},"records":[],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0018369\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>NCIT:C8111</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A malignant germ cell tumor arising from the ovary. It usually affects females in their first two decades of life. It contains variable amounts of immature embryonal tissues. Based on the amount of immature neuroepithelial component, immature teratomas are graded from 1 to 3. The stage and grade of the tumor and the grade of the metastatic tumor are the important factors that predict prognosis. The use of cisplatin-based combination chemotherapy has significantly improved the survival rates of the patients.</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0018369\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"immature-ovarian-teratoma","sourceDocuments":[{"name":"MONDO: immature ovarian teratoma","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0018369"}],"sourceNote":"","synonyms":["immature germ cell teratoma of ovary","immature germ cell teratoma of the ovary","immature ovarian teratoma","immature teratoma","immature teratoma of ovary","immature teratoma of the ovary","malignant germ cell teratoma of ovary","malignant germ cell teratoma of the ovary","malignant ovarian germ cell teratoma","malignant ovarian teratoma","malignant teratoma of ovary","malignant teratoma of the ovary","ovarian germ cell immature teratoma","ovarian immature germ cell teratoma","ovarian immature teratoma","ovarian malignant teratoma","ovary malignant teratoma"],"takeawayHtml":"","title":"immature ovarian teratoma"},"schemaVersion":1}
